Axsome Therapeutics (AXSM) Q2 2026 Earnings

May 4Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.35
-1.18
-1.01
-0.84

Details

Expected EPS
-0.844416
Actual EPS
-1.26
Surprise EPS
-0.42
Surprise Percent
-49.22%

Description

⁨Axsome Therapeutics⁩ (⁦AXSM⁩) has reported earnings of ⁦-1.26⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts